GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Adventa Bhd (XKLS:7191) » Definitions » Quality Rank

Adventa Bhd (XKLS:7191) Quality Rank


View and export this data going back to 2004. Start your Free Trial

What is Adventa Bhd Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Adventa Bhd Quality Rank Related Terms

Thank you for viewing the detailed overview of Adventa Bhd's Quality Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Adventa Bhd (XKLS:7191) Business Description

Traded in Other Exchanges
N/A
Address
No. 21, Jalan Tandang 51/205A, Seksyen 51, Petaling Jaya, SGR, MYS, 46050
Adventa Bhd is engaged in the business of medical services and related supplies manufacturing. The company's segments include Healthcare Business, Warehousing provider, and Corporate. It generates maximum revenue from the Healthcare Business segment. The healthcare business segment comprises the supply of healthcare and related products and services to hospitals, healthcare centres, and pharmacies. Previously, it also included the renal dialysis business which are both for home and centre-based treatments, serving both the domestic and export markets. Geographically, it derives a majority of revenue from Malaysia.